170421 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines Interleukins [IL]
Sub-classes:COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#2COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#3METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE
#4METHOD OF SELECTING PATIENTS FOR TREATMENT WITH AN IL-33 AXIS ANTAGONIST
#5ANTI-IL-27 ANTIBODIES AND USES THEREOF
#6METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#7METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#8MARKERS FOR DIAGNOSING INFECTIONS
#9BIOMARKERS
#10METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS
#11COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES
#12BRUCELLOSIS CELL IMMUNE PROTEIN AND USE THEREOF
#13METHODS OF TREATING IMMUNOTHERAPY-ASSOCIATED ADVERSE EFFECTS
#14COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#15VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#16COMBINATION ASSAY OF CYTOKINES AND HUMAN ANTIBODIES TO MAP FOR THE DIAGNOSIS OF CROHNS DISEASE, TUBERCULOSIS, AND OTHER BACTERIAL DISEASES
#17TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY
#18METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION
#19BOOSTED IMMUNE MONITORING METHODS FOR ASSAYING ANTIGEN-SPECIFIC T CELL RESPONSES
#20IL-18 BINDING PROTEIN (IL-18BP) IN THE TREATMENT OF VEXAS
#21ANTI-IL-27 ANTIBODIES AND USES THEREOF
#22Methods of Predicting Food Allergy
#23Serum Immune-Based Biomarkers for Use in ALS Therapy
#24METHOD OF IMPROVING THE CONSISTENCY AND/OR QUALITY OF A FELINE ANTIBODY
#25BIOMARKERS FOR EARLY DETECTION OF DIABETES
#26METHODS FOR TREATING BLADDER CANCER
#27Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#28IL-18 BINDING MOLECULES
#29MULTIPLEX CELLULAR ASSAYS FOR SCREENING AND QUALITY ASSESSMENT OF ENGINEERED CELLS
#30ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
#31Stabilized IL-18 Polypeptides and Uses Thereof
#32METHODS FOR QUANTIFYING IL-33
#33DEVELOPMENT OF FLEXIBLE PLASMONIC MEMBRANE-BASED SERS PLATFORM FOR MONITORING THE HEALING
#34VAGUS NERVE STIMULATION PRE-SCREENING TEST
#35COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS
#36Methods of Identifying Active Lupus Nephritis Flare
#37ANALYSIS OF EFFLUENT
#38IL-17A BINDING PROTEINS
#39IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases
#40INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#41USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION
#42IMMUNOMODULATORY CLINICAL BIOMARKER PROFILES AND USES THEREOF
#43METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT
#44INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#45ANTIBODY ANTI IL17
#46CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION
#47SIMULATED SYNOVIAL FLUIDS FOR MODELING DEGENERATIVE JOINT DISEASES AND SCREENING FOR THERAPEUTICS FOR SAME
#48PANCREATIC CANCER DIAGNOSTIC COMPOSITION TO BE USED IN BUFFY COAT SAMPLE
#49Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells
#50PREDICTION AND EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY
#51Treatment Of Lung Disease Based Upon Stratification Of Polygenic Risk Score For Interleukin 33 (IL-33)
#52ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS
#53METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#54Identification of contact lens wearers predisposed to contact lens discomfort
#55POTENCY ASSAY
#56METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#57KIDNEY HEALTH MONITORING IN HYPERTENSION PATIENTS
#58ANTI-IL-27 ANTIBODIES AND USES THEREOF
#59MATERIALS AND METHODS FOR INFLAMMATORY MOLECULAR MARKERS
#60USE OF CIRCULATING INTERLEUKIN-18 FOR PROGNOSTICATING AND TREATING RECURRENCE IN EARLY STAGE NON-SMALL CELL LUNG CANCER
#61MYCOBACTERIAL COMPOSITIONS AND BIOMARKERS FOR USE IN TREATMENT AND MONITORING OF THERAPEUTIC RESPONSIVENESS
#62PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATHWAY BIOMARKERS
#63COMPOSITIONS AND METHODS FOR AN IL-17 TARGET ENGAGEMENT ASSAY WITH LARGE MOLECULE MODULATORS
#64COMPOSITIONS AND METHODS FOR AN IL-17 TARGET ENGAGEMENT ASSAY WITH SMALL MOLECULE MODULATORS
#65BIOMARKER COMBINATIONS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#66NOVEL IL-17B ANTIBODIES
#67ANTI-IL-27 ANTIBODIES AND USES THEREOF
#68Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#69Interleukin-31 monoclonal antibodies for veterinary use
#70USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#71Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#72NOVEL CYTOKINES AND USE THEREOF
#73Anti-IL-23 antibodies, compositions, methods and uses
#74SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
#75Vagus nerve stimulation pre-screening test
#76METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#77BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#78Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
#79DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#80Method for diagnosis and subtyping of adult onset Still's disease
#81Antibodies to IL-34
#82ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF
#83Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
#84Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
#85PREDICTING MORTALITY AND DETECTING SEVERE DISEASE
#86Sustained Response Predictors After Treatment with Anti-IL23 Antibody
#87IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#88METHODS OF TREATING NEUROLOGICAL DISEASES AND DISORDERS
#89Selective peptide antagonists
#90Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#91Methods for quantifying IL-33
#92IL-17F-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#93IL-18 binding protein (IL-18BP) in inflammatory diseases
#94SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER
#95KIT FOR DETECTING SUBSET OF HUMAN REGULATORY T CELL, AND DETECTION METHOD THEREOF
#96IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#97IL-17A binding proteins
#98METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#99Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#100Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#101NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF
#102Anti-IL-23 antibodies, compositions, methods and uses
#103Methods for assessing treatment with a gastrointestinal implant
#104Methods of treating androgen deprivation therapy resistant prostate cancer
#105Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#106MODULATION OF NOVEL IMMUNE CHECKPOINT TARGETS
#107METHODS FOR TREATING IL-31-MEDIATED CONDITIONS IN COMPANION ANIMALS
#108Anti-IL-27 antibodies and uses thereof
#109IL-31 dog pruritus model
#110ANTIBODIES TO IL-37
#111Method for detecting the risk and prognosis of adult-onset Still's disease
#112Interleukin-31 monoclonal antibodies for veterinary use
#113Identification of contact lens wearers predisposed to contact lens discomfort
#114Methods of detecting human IL-21
#115PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#116Anti-IL-23 antibodies
#117COMPOSITIONS AND METHODS RELATING TO C5L2
#118Atopic dermatitis model non-human animal and use thereof
#119Anti-IL17A autoantibodies for treating or reducing the likelihood of occurrence of bone destruction associated with a chronic autoimmune or inflammatory disease
#120Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#121Method for identifying a bacterial infection
#122BIOMARKERS
#123Interleukin-31 monoclonal antibody
#124IL-18 binding molecules
#125CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
#126IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS
#127Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
#128Vagus nerve stimulation pre-screening test
#129Predicting mortality and detecting severe disease
#130Methods of Treating Subjects having Severe and/or Persistent Asthma
#131DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#132IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
#133Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#134Selective peptide antagonists
#135Identification of Biomarkers in Serum Samples Collected from Clinical Trials by Multiplex Technology
#136Compositions and methods to detect non-coeliac gluten sensitivity
#137Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
#138Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
#139POLYNUCLEOTIDES ENCODING MONOCLONAL ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F
#140Identification of CD8T cells that are CD161and/or IL18R(α)and have rapid drug efflux capacity
#141BIOMARKERS FOR PREDICTING A RESPONSE TO AN IMMUNOMODULATING TREATMENT IN PATIENTS WITH INFLAMMATORY DISEASE
#142COMPOSITIONS AND METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#143Prostate cancer-associated secreted proteins
#144METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#145METHODS OF TREATING WITH TUMOR MEMBRANE VESICLE-BASED IMMUNOTHERAPY AND PREDICTING THERAPEUTIC RESPONSE THERETO
#146Methods for Monitoring Responsiveness to Anti-SMAD7 Therapy
#147IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#148IL-17A binding proteins
#149METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISORDERS
#150Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#151Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44
#152DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#153Methods For Screening Therapeutic Compounds
#154T CELL-BOUND CYTOKINE ASSAY FOR ANTIGEN-SPECIFIC TOLERANCE
#155Anti IL-34 antibodies
#156Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#157Anti-IL-23 antibodies, compositions, methods and uses
#158Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
#159Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#160Methods and compositions for T cell generation and uses thereof
#161MONOVALENT BINDING PROTEINS
#162METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#163N-terminally truncated interleukin-38
#164Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34
#165Methods for treating medical conditions by anti-type 2 therapy
#166Specific biomarker set for non-invasive diagnosis of liver cancer
#167Diagnosis and treatment of Kawasaki disease
#168Predicting mortality and detecting severe disease
#169Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
#170Method for treating muscular dystrophy
#171IL-17F-specific capture agents, compositions, and methods of using and making
#172Diagnosis of cancer by detecting dimeric IL-18
#173IL-18 binding molecules
#174Biomarker and methods for early diagnosis of Alzheimer's disease
#175Monoclonal antibodies that bind both IL-17A and IL-17F
#176Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
#177Methods of developing selective peptide antagonists
#178Methods of Treating Subjects having Severe and/or Persistent Asthma
#179METHODS FOR IDENTIFYING MODULATORS OF IL-24 MEDIATED APOPTOSIS AND IMMUNOTHERAPY
#180COMPOSITIONS AND METHODS RELATING TO C5L2
#181Maternal TH17 cells and psychiatric disorders
#182PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#183IL-18 binding protein (IL-18BP) in inflammatory diseases
#184Biomarkers for predicting relapse in multiple sclerosis
#185Pharmaceutical composition for the treatment and/or prevention of disease involving abnormal accumulation of amyloid β protein
#186Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#187Highly Sensitive Biomarker Panels
#188Nanoelectronic-enzyme linked immunosorbent assay system and method
#189Aptamer to IL-17 and use thereof
#190Identification of CD8T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity
#191Method for identifying a bacterial infection
#192Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
#193Compositions and methods for modulating c-Rel-dependent cytokine production
#194METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS
#195Methods for predicting the survival time of a patient suffering from a solid cancer
#196Treatment of inflammation using alpha 7 receptor-binding agonists
#197DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
#198DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-13 AND/OR IL-17
#199Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
#200Anti-IL-23 antibodies
#201Biomarkers in inflammatory bowel disease
#202Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#203ACUTE KIDNEY INJURY
#204Biomarkers for the identification of liver damage
#205Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
#206CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS
#207COMPOSITIONS AND METHODS FOR DETECTING, TREATING AND MONITORING ACTIVE BORRELIA INFECTION
#208TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#209Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#210Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
#211Compositions and methods for detecting and treating colorectal cancer
#212BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#213DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#214Methods and devices for tuberculosis diagnosis using biomarker profiles
#215Methods of monitoring responsiveness to anti-SMAD7 therapy
#216Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
#217Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#218METHODS AND KITS FOR PREDICTING THE RISK OF HAVING A CARDIOVASCULAR EVENT IN A SUBJECT
#219Biomarkers
#220Method for monitoring HIV specific T cell responses
#221Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F
#222Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
#223Single Molecule Assays
#224RISK PREDICTORS FOR ADVERSE PERINATAL OUTCOMES
#225Method of isolating human antibodies
#226Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#227Nucleic acids encoding interleukin-31 monoclonal antibody and uses thereof
#228Biomarker panel for detecting lung cancer
#229Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#230Dual variable domain immunoglobulins and uses thereof
#231Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#232Anti-IL-23 Antibodies
#233Anti-IL-23 antibodies, compositions, methods and uses
#234Predicting mortality and detecting severe disease
#235Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#236Marker and reagent for detection of human IL-17-producing helper T cells, and method for detection of human IL-17-producing helper T cells
#237METHODS FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A SOLID CANCER
#238IL-17 HOMOLOGOUS POLYPEPTIDES AND THEREAPEUTIC USES THEREOF
#239BIOMARKERS
#240Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease
#241Interleukin-31 monoclonal antibody
#242Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#243PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#244Anti-IL-23 antibodies
#245METHODS FOR DIAGNOSIS OF IMMUNE RESPONSES AGAINST VIRUSES
#246Interleukin-10 antibodies
#247METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR
#248INDICATOR AGENT FOR NONINFLAMMATORY STRESS RESPONSE AND USE THEREOF
#249DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#250COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION
#251TRI-VARIABLE DOMAIN BINDING PROTEINS AND USES THEREOF
#252BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES
#253METHODS OF TREATMENT USING AN ANTI IL B50 ANTIBODY
#254Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
#255MARKER AND REAGENT FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS, AND METHOD FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS
#256Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#257Semi-Invasive Method for Characterizing Lung Injury
#258BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#259IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#260IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#261Methods of identifying a subject as having heart failure
#262Dual variable domain immunoglobulins and uses thereof
#263IL-18 RECEPTOR AS A NOVEL TARGET OF REGULATORY T CELLS IN CANCER
#264METHODS FOR GENERATING ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#265Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#266DIFFERENTIAL DIAGNOSTIC BIOMARKERS OF STROKE MIMICKING CONDITIONS AND METHODS OF USE THEREOF
#267Antisense modulation of interleukins 17 and 23 signaling
#268Predicting mortality and detecting severe disease
#269MARKERS FOR DETERMINATION OF PATIENT RESPONSIVENESS
#270TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS
#271SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#272Markers for determination of patient responsiveness
#273Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#274Process for the measurement of the potency of glatiramer acetate
#275Methods of screening for and treating autism spectrum disorders and compositions for same
#276Aptamer against IL-17 and use thereof
#277TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#278Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
#279Identifcation of CD8 T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity
#280Biomarker
#281MARKER FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL, AND METHOD FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL
#282Highly sensitive biomarker panels
#283Methods and Uses of Anti-IL-23 Antibodies
#284ASSAY
#285Antibodies that bind both IL-17A and IL-17F
#286Mechanically actuated diagnostic device
#287Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients
#288TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#289ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES
#290IL-21 RECEPTOR KNOCKOUT ANIMAL AND METHODS OF USE THEREOF
#291DIAGNOSTIC METHOD AND PROGNOSTIC TOOL FOR OSTEOARTHRITIS
#292Interleukin-10 antibodies
#293Nanoelectronic-enzyme linked immunosorbent assay system and method
#294Making a prognosis in cases of cardiac disease using a combination of markers
#295SINGLE MOLECULE ASSAYS
#296IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS
#297CYTOKINE RECEPTOR CHAIN
#298METHODS FOR PREDICTING PRODUCTION OF ACTIVATING SIGNALS BY CROSS-LINKED BINDING PROTEINS
#299Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
#300Fusion proteins and methods for modulation of immune response